Evaluation of antimicrobial resistance of Acinetobacter baumannii to imipenem, ciporofloxacin and ceftazidime using E test

Iranian Journal of Public Health

Volumn 38, Issue 2, 2009, Pages 130-133

  Boroumand, M A ^a   Akhyani, H ^a   Sheikhvatan, M ^a   Yazdi, S Hekmat ^b   Saboorian, R ^b   Hashemi, Sh ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Reference Laboratories of Iran Research Center   (Iran)

Author keywords

Acinetobacter; Antimicrobial susceptibility; Ceftazidime; Ciprofloxacin; E test; Imipenem

Indexed keywords

EID: 68649119322     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Curtis LT (2008). Prevention of hospitalacquired infections: review of non-pharmacological interventions. J Hosp Infect, 69(3): 204-19.
2. Lagamayo EN (2008). Antimicrobial resistance in major pathogens of hospitalacquired pneumonia in Asian countries. Am J Infect Control, 36(4):101-8.
3. Podnos YD, Cinat ME, Wilson SE, Cooke J, Gornick W, Thrupp LD (2001). Eradication of multi-drug resistant Acinetobacter from an intensive care unit. Surg Infect (Larchmt), 2(4): 297-301.
4. Afzal-Shah M, Livermore DM (1998). Worldwide emergence of carbapenem-resistant Acinetobacter spp. J Antimicrob Chemother, 41(5): 576-77.
5. Andrews HJ (1986) Acinetobacter bacteriocin typing. J Hosp Infect, 7(2): 169-75.
6. Prashanth K, Badrinath S (2004). In vitro susceptibility pattern of acinetobacter species to commonly used cephalosporins, quinolones, and aminoglycosides. Indian J Med Microbiol, 22(2):97-103.
7. Amor A, Barguellil F, Othmani S, Bahri M (1993). Infections à Acinetobacter baumannii et apport bactériologique. Semin Hop, 69(2): 732-35.
8. Vila J, Marcos A, Marco F, Abdalla S, Bergara Y, et al (1993). In vitro antimicrobial production of b-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 37(1):138-41.
9. Jamulitrat S, Thongpiyapoom S, Suwalak N (2007). An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis. J Med Assoc Thai, 90(10): 2181-91.
10. Oteo J, García-Estébanez C, Migueláñez S, Campos J, Martí S, Vila J, Domínguez MA, Docobo F, Larrosa N, Pascual A, Pintado V, Coll P, Red Española de Investigación en Patología Infecciosa (2007). Genotypic diversity of imipenem resistant isolates of Acinetobacter baumannii in Spain. J Infect, 55(3): 260-6.
11. Aarestrup FM (1999). Association between the consumption of antimicrobial agents in animal husbandry and the occurrence of resistant bacteria among food animals. Int J Antimicrob Agents, 12(4): 279-85.
12. Ranjbar R, Sadeghifard N, Ahmadi A, Izadi M, Zaeimi-Yazdi J, Ghasemi A, Qurbanalizadgan M, Rostamzad A (2007). Antimicrobial susceptibility and AP-PCR typing of Acinetobacter spp. strains. Iranian J Publ Health, 36(4):50-56.
13. Simhon A, Rahav G, Shazberg G, Block C, Bercovier H, Shapiro M (2001). Acinetobacter baumannii at a Tertiary-Care Teaching Hospital in Jerusalem. J Clin Microbiol, 39(1): 389-91.
14. Health Protection Agency (2004). Acinetobacter spp bacteraemia, England, Wales, and Northern Ireland. CDR Weekly. Available from: www.comr.org.uk.